Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04728295 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04728295 · ClinicalTrials.gov record · last posted 2025-02-17

Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)

StatusActive, Not Recruiting
PhaseNot applicable
SponsorInSightec
Started2021-05-14
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Evaluate the Safety and Effectiveness of Staged Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD).

Amendment record 11 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 11 times since 2021-01-26; most recent amendment 2025-02-13. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2022-07-11
Status change Recruiting→Active, Not Recruitingv10
2021-05-14
Status change Not Yet Recruiting→Recruitingv3
Trial Details
NCT Number NCT04728295
Lead Sponsor InSightec
Conditions Parkinson Disease
Enrollment 50 participants
Start Date 2021-05-14
Primary Completion 2024-03-28 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-17